- Home
- EUDA vs SGHT Comparison
EUDA vs SGHT Comparison
Compare EUDA & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EUDA
- SGHT
- Stock Information
- Founded
- EUDA 2021
- SGHT 2011
- Country
- EUDA Singapore
- SGHT United States
- Employees
- EUDA N/A
- SGHT N/A
- Industry
- EUDA Blank Checks
- SGHT Medical Specialities
- Sector
- EUDA Finance
- SGHT Health Care
- Exchange
- EUDA Nasdaq
- SGHT Nasdaq
- Market Cap
- EUDA 152.3M
- SGHT 140.1M
- IPO Year
- EUDA N/A
- SGHT 2021
- Fundamental
- Price
- EUDA $3.82
- SGHT $3.05
- Analyst Decision
- EUDA
- SGHT Buy
- Analyst Count
- EUDA 0
- SGHT 7
- Target Price
- EUDA N/A
- SGHT $3.83
- AVG Volume (30 Days)
- EUDA 107.3K
- SGHT 196.0K
- Earning Date
- EUDA 01-01-0001
- SGHT 05-08-2025
- Dividend Yield
- EUDA N/A
- SGHT N/A
- EPS Growth
- EUDA N/A
- SGHT N/A
- EPS
- EUDA N/A
- SGHT N/A
- Revenue
- EUDA $3,811,496.00
- SGHT $79,866,000.00
- Revenue This Year
- EUDA $66.63
- SGHT N/A
- Revenue Next Year
- EUDA $102.75
- SGHT $11.17
- P/E Ratio
- EUDA N/A
- SGHT N/A
- Revenue Growth
- EUDA N/A
- SGHT N/A
- 52 Week Low
- EUDA $1.75
- SGHT $2.03
- 52 Week High
- EUDA $6.30
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- EUDA 49.40
- SGHT 56.82
- Support Level
- EUDA $3.70
- SGHT $2.40
- Resistance Level
- EUDA $3.86
- SGHT $3.44
- Average True Range (ATR)
- EUDA 0.22
- SGHT 0.25
- MACD
- EUDA -0.00
- SGHT 0.06
- Stochastic Oscillator
- EUDA 50.12
- SGHT 64.62
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.